Asian markets traded mixed on Wednesday November 4, as investors weighed early signs that Democrats could win control of Congress and the gridlock in Washington that might follow.
The MSCI Asia Pacific Index edged up 0.1% as most regional markets opened higher.
Wall Street stocks finished mostly higher as oil prices continued to pull back while markets awaited results from US midterm elections that could reshape President Donald Trump's final two years in office.
Here's a table showing how US stocks performed on Tuesday:
Stock/Index | LTP | Change ($) | Change (%) | Day High | Day Low | 52-Week High | 52-Week Low |
|---|---|---|---|---|---|---|---|
Alphabet | 278.27 | 0.23 | 0.08% | 280.34 | 272 | 404.44 | 271.41 |
Apple | 331.9 | -6.42 | -1.90% | 334.5 | 325.33 | 351.73 | 243.42 |
Meta | 621.03 | 14.3 | 2.36% | 624.84 | 610.1 | 779.82 | 520.26 |
Tesla | 398.5 | -5.32 | -1.32% | 406.5 | 396.53 | 498.82 | 297.38 |
Netflix | 63.42 | 1.08 | 1.73% | 63.47 | 61.9 | 116.73 | 61.4 |
Amazon | 250.69 | 5.06 | 2.06% | 252.45 | 245.88 | 287.16 | 196 |
Microsoft | 520.99 | 13.87 | 2.74% | 523.44 | 507.82 | 551.15 | 349.2 |
Dow Jones | 51786.72 | -197.26 | -0.38% | 51932.63 | 51593.16 | 54744.33 | 45057.28 |
Nasdaq | 28180.26 | 190.44 | 0.68% | 28307.9 | 28085.5 | 31361.37 | 22841.42 |
Source: Equitymaster
At present, the BSE Sensex is trading 319 points higher, and NSE Nifty is trading 87 points higher.
Emcure Pharma, Jyoti CNC Auto and Sapphire Foods are the top gainers today.
JSW Holdings, Schaeffler India and HFCL on the other hand is among the top losers today.
The BSE 150 Midcap index and the BSE 250 SmallCap index is trading marginally high.
Sectoral indices are trading mixed today with stocks in FMCG sector and oil & gas sector witnessing buying. Meanwhile stocks in IT sector and telecom sector witnessing selling pressure.
The rupee is trading at Rs 94.52 against the US dollar.
Happiest Minds Q2 Results
Happiest Minds Technologies, a small-tier IT services provider, reported revenue of Rs 6,454 million for the second quarter, up 12.5% year-on-year (YoY) and 2.7% quarter-on-quarter (QoQ).
In constant currency terms, the topline grew 6.8% YoY.
Happiest Minds Technologies reported a 15.1% YoY rise in net profit to Rs 621 million for the September quarter, even as slower client decision-making amid uncertainty over artificial intelligence (AI) weighed on its performance. Sequentially, net profit contracted 8%.
Venkatraman Narayanan, managing director of Happiest Minds, said the company was behind its target of 12.5% constant currency revenue growth, even as the demand scenario remained relatively favourable.
Bata India Q2 Results
Leading shoemaker Bata India reported a 30.4% YoY rise in consolidated net profit to Rs 181.1 million in the September quarter of FY27, supported by a higher average selling price (ASP).
It had posted a net profit of Rs 138.9 million in the July-September period a year ago, according to a regulatory filing.
Revenue from operations increased 7.54% to Rs 8,617.8 million in the September quarter of FY27, compared with Rs 8,013.3 million in the corresponding quarter a year ago.
The company said revenue grew 7.5% despite the festive calendar largely shifting to Q3 this year. Profit after tax for the quarter grew over 31%, supported by a higher ASP, according to its earnings statement.
Lupin Q2 Results
Homegrown pharmaceutical major Lupin reported a 22.19% year-on-year (YoY) decline in consolidated net profit to Rs 11,553 million in the September quarter of FY27, primarily due to an exceptional item.
The company had reported a net profit of Rs 14,848.3 million in the corresponding quarter of the previous financial year, according to its regulatory filing.
Revenue from operations increased to Rs 78,272.6 million during the quarter under review, compared with Rs 70,475.1 million in the year-ago period.
Lupin's total expenses also rose to Rs 63,744.6 million during the quarter from Rs 51,305.4 million in the corresponding period last year.
For the first half of FY27, Lupin's net profit declined 4.95% to Rs 25,722.8 million from Rs 27,062.9 million a year earlier.
During the six months ended 30 September 2026, Lupin Pharmaceuticals Inc., USA, a wholly owned subsidiary of the group, settled one of its ongoing antitrust matters for Rs 3,162.8 million (US$35.8 million), without admitting liability or wrongdoing.
The company added that it continues to maintain provisions for future settlements related to similar cases.
MCX Q2 Results
Multi Commodity Exchange of India (MCX) reported a 130% year-on-year (YoY) surge in consolidated net profit to Rs 4,545.7 million in the second quarter of FY27 (Q2FY27), compared with Rs 1,974.7 million in the corresponding quarter of the previous financial year.
The exchange recorded a significant increase in profitability during the quarter, with net profit more than doubling from the year-ago period. The strong growth highlights MCX's improved financial performance during the September quarter.
Comments
Log in or sign up to join the conversation.